News | June 30, 2025
Biocon Biologics expands insulin access in Malaysia
Over 100 million cartridges of rh-insulin supplied to Malaysian health ministry; 345,000+ patients served
Over 100 million cartridges of rh-insulin supplied to Malaysian health ministry; 345,000+ patients served
The company was awarded the insulins supply contract for a three-year period in 2022 through April 2025
There are 38.4 million people with diabetes in the United States
The huminsulin range of products is indicated for the treatment of type 1 and type 2 diabetes mellitus to improve blood sugar control in both adults and childre
Afrezza, developed by MannKind Corporation in the USA, offers a needle-free, rapid-acting insulin option for diabetes management
The market size of Aspart in India is currently estimated over Rs. 260 crore with only 2 players
The inspection concluded with the issuance of a form 483 with five observations
The company had submitted a comprehensive Corrective and Preventive Action (CAPA) plan in September 2022
The agency issued a Form 483 with 6 observations for Drug Substance, Drug Product units and Quality Control laboratories
The CRL did not identify any outstanding scientific issues with the product.
Subscribe To Our Newsletter & Stay Updated
